Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
BJOG : an International Journal of Obstetrics and Gynaecology|June 17, 2004
Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancerAlessandro D Santin, Mepur H Ravindranath, Stefania Bellone, et al.Internal and Emergency Medicine|February 5, 2016
Combination evidence-based therapy is effective in the oldest 'old patients' following myocardial infarction. The "Salute e Benessere nell'Anziano" (SeBA) observational studyMauro Di Bari, Luca Degli Esposti, Chiara Veronesi, et al.Infection|May 6, 2015
Chlamydia trachomatis genotypes in school adolescents, ItalyPaola Stefanelli, Giorgia Sulis, Giovanna Renna, et al.Journal of Virology|December 7, 2007
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trialAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.Gynecologic Oncology|May 27, 2006
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapyEliana Bignotti, Renata A Tassi, Stefano Calza, et al.Cancer|February 28, 2007
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)Alessandro D Santin, Stefania Bellone, Moira Marizzoni, et al.Gynecologic Oncology|October 27, 2005
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalitiesAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.Gynecologic Oncology|April 2, 2011
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.Gynecologic Oncology|June 2, 2007
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic diseaseStefania Bellone, Gianluca Frera, Gianpiero Landolfi, et al.American Journal of Obstetrics and Gynecology|July 30, 2013
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2)Diana P English, Stefania Bellone, Emiliano Cocco, et al.Pageof 13